About the Omni Processor Technology Portfolio
Stemming from the Reinvent the Toilet Challenge in 2011, the Gates Foundation’s “Omni -Processor” portfolio was conceived to “reinvent the sewage treatment plant” to help address this challenge. An “Omni-Processor”, or OP, is an innovative treatment system that treats sludge to achieve complete pathogen destruction while generating useful byproducts that can help offset project costs. The OP is a component of a full fecal sludge or biosolids treatment plant- further detail on the required pre-processing and liquid treatment is described below.
Different communities may need different treatment capacities and different approaches. The BMGF OP portfolio currently consists of three core technologies that can be scaled to suit the needs of the community: the J-OP, Tide Technocrats pyrolysis, and Duke University super-critical water oxidation. Learn more about the OP technologies here.
Resources Available on the Omni Processor
The following key questions are addressed:
- What is the global market opportunity for the Omni Processor portfolio? What are the use cases for the Omni Processor technologies?
- What are the economics of the OP portfolio? How do I build the business case (including output valuation)?
- What is the value proposition of the OP? How does the OP compare against existing sanitation solutions?
- What are the go-to-market considerations?
What is the global market opportunity for the Omni Processor portfolio? What are the use cases for the Omni Processor technologies?
- What is the global market size for the J-OP?
- Which cities could have adequate fecal sludge volumes to support a system?
What are the economics of the OP portfolio? How do I build the business case (including output valuation)?
What is the value proposition of the OP?
What are the go-to-market considerations?
STeP has developed resources to explore the questions of: how does a partner enter the market? Where have successful models been established? And how can a city attract investment for a new OP? The reports below summarize our findings.